원심 혈액 펌프 시장 : 제품 유형, 기술, 최종 용도, 용도, 유통 채널별 - 세계 예측(2025-2030년)

The Centrifugal Blood Pumps Market was valued at USD 83.80 million in 2023, expected to reach USD 88.05 million in 2024, and is projected to grow at a CAGR of 5.42%, to USD 121.26 million by 2030.

The global centrifugal blood pumps market is positioned within the broader medical devices sector, primarily focused on providing circulatory support for patients with cardiac conditions. These pumps are essential during cardiac surgeries and for patients suffering from heart failure, offering a temporary solution to support heart function and ensure adequate blood flow. The necessity of centrifugal blood pumps arises from the increasing prevalence of cardiovascular diseases, the continuous advancements in surgical procedures, and the growing need for effective extracorporeal circulatory systems across various health conditions. Applications span from surgical procedures like open-heart surgeries to support in ventricular assist devices and extracorporeal membrane oxygenation (ECMO) systems. Key end-use segments include hospitals, specialized cardiac centers, and ambulatory surgical centers.

Market growth is significantly influenced by advancements in pump technology, which aim to enhance safety and efficacy, as well as the rising incidence of cardiac disorders globally. Additionally, the aging population and subsequent increase in age-related cardiac issues are contributing to heightened demand. Emerging opportunities are noted in developing countries due to expanding healthcare infrastructure and awareness, which necessitates strategic partnerships and expansions into these regions. However, the market faces limitations such as the high cost of devices, stringent regulatory approvals, and potential complications associated with their use, which can impede widespread adoption.

For business growth, innovation in miniaturized and more efficient pump systems that offer better biocompatibility and ease of integration into existing treatment protocols is crucial. Research focusing on reducing pump-related complications and enhancing device sustainability can significantly boost market prospects. Despite these challenges, the market remains dynamic, driven by technological advancements and a strong demand-supply chain in the healthcare sector. Companies that invest in R&D, coupled with strategic market penetration in underdeveloped regions, stand the best chance of maximizing business growth in this field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Centrifugal Blood Pumps Market

The Centrifugal Blood Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence and surgeries of cardiovascular and kidney disorders
  • Technological advancements in pump design, a growing geriatric population
  • Rising demand for minimally invasive procedures
• Market Restraints
  • Presence of low cost counterfeit blood pumps
• Market Opportunities
  • Emergence of smart blood pumps equipped with sensors and IoT
  • Increasing investment in healthcare infrastructure
• Market Challenges
  • Regulatory approvals and clinical trials of centrifugal blood pumps

Porter's Five Forces: A Strategic Tool for Navigating the Centrifugal Blood Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Centrifugal Blood Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Centrifugal Blood Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Centrifugal Blood Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Centrifugal Blood Pumps Market

A detailed market share analysis in the Centrifugal Blood Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Centrifugal Blood Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Centrifugal Blood Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Centrifugal Blood Pumps Market

A strategic analysis of the Centrifugal Blood Pumps Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Centrifugal Blood Pumps Market, highlighting leading vendors and their innovative profiles. These include ", "Qura S.r.l, 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, BiVACOR, Pty. Ltd., Braile Biomedica Ltda., F. Hoffmann-La Roche Ltd., Getinge AB, Grundfos Holding A/S, Hitachi, Ltd., Hugo Sach Elektronik by Harvard Apparatus, Inc., JOSTRA GmbH, KYOCERA Medical Technologies, Inc., Levitronix LLC, LivaNova, Inc., Medtronic PLC, Perfusion.com, Inc., Senko Medical Instrument Mfg. Co., Ltd., Sulzer Ltd., Terumo Corporation, and XENIOS AG by Fresenius Medical Care Company.

Market Segmentation & Coverage

This research report categorizes the Centrifugal Blood Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Disposable Centrifugal Blood Pumps and Reusable Centrifugal Blood Pumps.
• Based on Type, market is studied across Electronic and Mechanical.
• Based on Technology, market is studied across Conventional Centrifugal Blood Pumps, Hybrid, and Magnetic Levitation.
• Based on End-Use, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Application, market is studied across Cardiac Surgery, Extracorporeal Membrane Oxygenation, and Respiratory Support.
• Based on Distribution Channel, market is studied across Direct Sales, Distributors, and Online Retail.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence and surgeries of cardiovascular and kidney disorders
    • 5.1.1.2. Technological advancements in pump design, a growing geriatric population
    • 5.1.1.3. Rising demand for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Presence of low cost counterfeit blood pumps
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of smart blood pumps equipped with sensors and IoT
    • 5.1.3.2. Increasing investment in healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory approvals and clinical trials of centrifugal blood pumps
• 5.2. Market Segmentation Analysis
  • 5.2.1. Diverse scope of applications of centrifugal blood pumps in cardiac surgery
  • 5.2.2. Ongoing innovations in reusable centrifugal blood pump for diverse healthcare needs
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Centrifugal Blood Pumps Market, by Product

• 6.1. Introduction
• 6.2. Disposable Centrifugal Blood Pumps
• 6.3. Reusable Centrifugal Blood Pumps

7. Centrifugal Blood Pumps Market, by Type

• 7.1. Introduction
• 7.2. Electronic
• 7.3. Mechanical

8. Centrifugal Blood Pumps Market, by Technology

• 8.1. Introduction
• 8.2. Conventional Centrifugal Blood Pumps
• 8.3. Hybrid
• 8.4. Magnetic Levitation

9. Centrifugal Blood Pumps Market, by End-Use

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Ambulatory Surgical Centers
• 9.4. Hospitals
• 9.5. Specialty Clinics

10. Centrifugal Blood Pumps Market, by Application

• 10.1. Introduction
• 10.2. Cardiac Surgery
• 10.3. Extracorporeal Membrane Oxygenation
• 10.4. Respiratory Support

11. Centrifugal Blood Pumps Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Direct Sales
• 11.3. Distributors
• 11.4. Online Retail

12. Americas Centrifugal Blood Pumps Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Centrifugal Blood Pumps Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Centrifugal Blood Pumps Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. CytoSorbents launches PuriFi hemoperfusion pump in EU
  • 15.3.2. BiVacor secures USD 13 million grant for innovative total artificial heart development and clinical trials in heart failure treatment
  • 15.3.3. Abbott's CentriMag Blood Pump gets FDA clearances for extended life support and urgent care enhancements
  • 15.3.4. Abbott boosts vascular disease treatment portfolio with USD 890 million acquisition of Cardiovascular Systems Inc.
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. "
• 2. "Qura S.r.l
• 3. 3M Company
• 4. Abbott Laboratories
• 5. B. Braun Melsungen AG
• 6. Baxter International Inc.
• 7. Becton, Dickinson and Company
• 8. BiVACOR, Pty. Ltd.
• 9. Braile Biomedica Ltda.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Getinge AB
• 12. Grundfos Holding A/S
• 13. Hitachi, Ltd.
• 14. Hugo Sach Elektronik by Harvard Apparatus, Inc.
• 15. JOSTRA GmbH
• 16. KYOCERA Medical Technologies, Inc.
• 17. Levitronix LLC
• 18. LivaNova, Inc.
• 19. Medtronic PLC
• 20. Perfusion.com, Inc.
• 21. Senko Medical Instrument Mfg. Co., Ltd.
• 22. Sulzer Ltd.
• 23. Terumo Corporation
• 24. XENIOS AG by Fresenius Medical Care Company